Home › Funds › NEVILLE RODIE & SHAW INC › JNJ

NEVILLE RODIE & SHAW INC position in JNJ

JOHNSON JOHNSON · Health Care

NEVILLE RODIE & SHAW INC reported holding 166,623 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$44.1M, representing 3.09% of its reported portfolio and ranking #6 among its reported holdings. NEVILLE RODIE & SHAW INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)166.62K sh
Reported value held$44.11M
Portfolio Weight3.09%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How NEVILLE RODIE & SHAW INC's JNJ position evolved

NEVILLE RODIE & SHAW INC first disclosed a stake in JNJ in Q3 2023 at 229,091 shares (US$35.7M). The position peaked in Q3 2026 at 166,623 shares, worth US$44.1M. Across 13 filings, NEVILLE RODIE & SHAW INC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 166,623 shares valued at US$44.1M — a reduction of -1,565 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 229.09K $35.68M New
Q4 2023 225.34K $35.32M Reduce
Q1 2024 220.10K $34.82M Reduce
Q2 2024 188.98K $27.62M Reduce
Q3 2024 180.77K $29.30M Reduce
Q4 2024 179.39K $25.94M Reduce
Q1 2025 172.09K $28.54M Reduce
Q2 2025 169.24K $25.85M Reduce
Q3 2025 162.68K $30.16M Reduce
Q4 2025 166.19K $34.39M Add
Q1 2026 169.93K $41.54M Add
Q2 2026 168.19K $42.71M Reduce
Q3 2026 166.62K $44.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has NEVILLE RODIE & SHAW INC held JNJ?

NEVILLE RODIE & SHAW INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is NEVILLE RODIE & SHAW INC's current position in JNJ?

As of Q3 2026, NEVILLE RODIE & SHAW INC holds 166.62K shares of JNJ (JOHNSON JOHNSON), valued at $44.11M, representing 3.09% of its reported portfolio and ranking #6.

Has NEVILLE RODIE & SHAW INC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), NEVILLE RODIE & SHAW INC reduced its position in JNJ. The position peaked in Q3 2026 at 166.62K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.